2 periods filed. Holdings below describe the selected month only.
NPORT-P/A · filed 2026-05-20
8 classes of this one portfolio · 0 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000025491 | GGOAX | NOT_LISTED | not exchange-listed | — |
| C000025493 | GGOCX | NOT_LISTED | not exchange-listed | — |
| C000025489 | GGOIX | NOT_LISTED | not exchange-listed | — |
| C000055753 | GGORX | NOT_LISTED | not exchange-listed | — |
| C000025490 | GGOSX | NOT_LISTED | not exchange-listed | — |
| C000055754 | GGOTX | NOT_LISTED | not exchange-listed | — |
| C000161552 | GGOUX | NOT_LISTED | not exchange-listed | — |
| C000200233 | GGQPX | NOT_LISTED | not exchange-listed | — |
N-PORT Item C.4.b
as filed
N-PORT Item C.4.a
70 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | 558868105 US5588681057 | EC CORP | 15,660 NS |
| $9.35M |
| 0.946% |
| US |
| Coherent Corp | COHR | 19247G107 US19247G1076 | EC CORP | 55,501 NS | $9.12M | 0.922% | US |
| Domino's Pizza Inc | DPZ | 25754A201 US25754A2015 | EC CORP | 21,688 NS | $9.10M | 0.920% | US |
| On Holding AG | ONON | 000000000 CH1134540470 | EC CORP | 185,350 NS | $8.15M | 0.825% | CH |
| Neurocrine Biosciences Inc | NBIX | 64125C109 US64125C1099 | EC CORP | 53,093 NS | $8.08M | 0.817% | US |
| Alnylam Pharmaceuticals Inc | ALNY | 02043Q107 US02043Q1076 | EC CORP | 17,777 NS | $8.02M | 0.811% | US |
| Lennar Corp | LEN | 526057104 US5260571048 | EC CORP | 60,183 NS | $7.90M | 0.799% | US |
| Samsara Inc | IOT | 79589L106 US79589L1061 | EC CORP | 205,843 NS | $7.83M | 0.792% | US |
| Argenx SE | ARGX | 04016X101 US04016X1019 | EC CORP | 7,771 NS | $7.09M | 0.717% | NL |
| Roivant Sciences Ltd | ROIV | 000000000 BMG762791017 | EC CORP | 328,379 NS | $6.83M | 0.691% | US |
| Rocket Lab Corp | RKLB | 773121108 US7731211089 | EC CORP | 146,120 NS | $6.16M | 0.623% | US |
| Rocket Cos Inc | RKT | 77311W101 US77311W1018 | EC CORP | 306,663 NS | $6.13M | 0.620% | US |
| Casey's General Stores Inc | CASY | 147528103 US1475281036 | EC CORP | 10,632 NS | $6.07M | 0.613% | US |
| ITT Inc | ITT | 45073V108 US45073V1089 | EC CORP | 32,771 NS | $6.04M | 0.610% | US |
| Marvell Technology Inc | MRVL | 573874104 US5738741041 | EC CORP | 66,199 NS | $5.92M | 0.599% | US |
| Klarna Group PLC | KLAR | 000000000 GB00BMHVL512 | EC CORP | 175,984 NS | $5.54M | 0.560% | GB |
| Nasdaq Inc | NDAQ | 631103108 US6311031081 | EC CORP | 58,211 NS | $5.29M | 0.535% | US |
| Builders FirstSource Inc | BLDR | 12008R107 US12008R1077 | EC CORP | 44,212 NS | $4.96M | 0.502% | US |
| GOLDMAN SACHS FINANCIAL SQUARE FUNDS PRIME OB… | — | 000000000 — | STIV RF | 3,757,763.89 NS | $3.76M | 0.380% | US |
| West Pharmaceutical Services I West Pharmaceutical Services Inc | WST | 955306105 US9553061055 | EC CORP | 10,762 NS | $2.98M | 0.302% | US |
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 97.3% of reported value reaches a classification.
Percentages are of the reported value of positions above ($1.00B), not of the fund’s net assets ($988.70M). The two differ by cash, derivatives filed with no market value, and rounding.